The Europe Opioids Market is expected to witness market growth of 3.3% CAGR during the forecast period (2021 2027).
Chronic pain can be caused by a variety of factors. It could have started with an illness or an injury that a patient had already recovered from, yet the agony persisted. There could also be a long-term source of pain, such as arthritis or cancer. Many people experience chronic pain without ever having been injured or showing any signs of sickness.
Also, chronic pain has an impact on every aspect of the patient's life. Symptom alleviation and support are two of the most effective treatments. In order to give the necessary therapies to assist manage the pain, a multidisciplinary approach to pain management is frequently required. Outpatient pain management programs are the most common.
Depression (sometimes known as clinical depression or severe depressive disorder) is a common but significant mood illness. It creates severe symptoms that impact how individuals feel, think, and cope with daily tasks like sleeping, eating, and working. The symptoms of depression must be present for at least two weeks in order to be identified.
The United Kingdom's healthcare system, popularly known as the NHS, is a well-known and comprehensive system that is mostly sponsored by the government. It is considered to be one of the most effective and extensive healthcare systems in the world. The United Kingdom has the greatest level of spending in Europe, which is unsurprising. Furthermore, increased research efforts, increased pipeline medications, and the presence of multiple large businesses in the country present a huge opportunity for opioids in the country. The rise in the government investment in healthcare sector is expected to also create more growth opportunities for the key market players.
German regulatory authorities' favourable payment policies in the areas of palliative care, non-abusive opioids, and opioid maintenance treatment (OMT) to treat opioid dependence (OD) have boosted potential in the opioids field.
The Germany market dominated the Europe Opioids Market by Country in 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $356.7 million by 2027. The UK market anticipated to grow at a CAGR of 2.5% during (2021 - 2027). Additionally, The France market is expected to showcase a CAGR of 4% during (2021 - 2027).
Based on Application, the market is segmented into Pain Management, Cough Treatment and Diarrhea Treatment. Based on Product Type, the market is segmented into Methadone, Oxycodone, Hydrocodone, Fentanyl, Codeine, Morphine and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, AstraZeneca PLC, Boehringer Ingelheim International GmbH, Endo International PLC, Mallinckrodt PLC, Sanofi S.A., Pfizer, Inc., Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Ltd., and Purdue Pharma L.P.
Chronic pain can be caused by a variety of factors. It could have started with an illness or an injury that a patient had already recovered from, yet the agony persisted. There could also be a long-term source of pain, such as arthritis or cancer. Many people experience chronic pain without ever having been injured or showing any signs of sickness.
Also, chronic pain has an impact on every aspect of the patient's life. Symptom alleviation and support are two of the most effective treatments. In order to give the necessary therapies to assist manage the pain, a multidisciplinary approach to pain management is frequently required. Outpatient pain management programs are the most common.
Depression (sometimes known as clinical depression or severe depressive disorder) is a common but significant mood illness. It creates severe symptoms that impact how individuals feel, think, and cope with daily tasks like sleeping, eating, and working. The symptoms of depression must be present for at least two weeks in order to be identified.
The United Kingdom's healthcare system, popularly known as the NHS, is a well-known and comprehensive system that is mostly sponsored by the government. It is considered to be one of the most effective and extensive healthcare systems in the world. The United Kingdom has the greatest level of spending in Europe, which is unsurprising. Furthermore, increased research efforts, increased pipeline medications, and the presence of multiple large businesses in the country present a huge opportunity for opioids in the country. The rise in the government investment in healthcare sector is expected to also create more growth opportunities for the key market players.
German regulatory authorities' favourable payment policies in the areas of palliative care, non-abusive opioids, and opioid maintenance treatment (OMT) to treat opioid dependence (OD) have boosted potential in the opioids field.
The Germany market dominated the Europe Opioids Market by Country in 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $356.7 million by 2027. The UK market anticipated to grow at a CAGR of 2.5% during (2021 - 2027). Additionally, The France market is expected to showcase a CAGR of 4% during (2021 - 2027).
Based on Application, the market is segmented into Pain Management, Cough Treatment and Diarrhea Treatment. Based on Product Type, the market is segmented into Methadone, Oxycodone, Hydrocodone, Fentanyl, Codeine, Morphine and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, AstraZeneca PLC, Boehringer Ingelheim International GmbH, Endo International PLC, Mallinckrodt PLC, Sanofi S.A., Pfizer, Inc., Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Ltd., and Purdue Pharma L.P.
Scope of the Study
Market Segments Covered in the Report:
By Application
- Pain Management
- Cough Treatment and
- Diarrhea Treatment
By Product Type
- Methadone
- Oxycodone
- Hydrocodone
- Fentanyl
- Codeine
- Morphine and
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Johnson & Johnson
- AstraZeneca PLC
- Boehringer Ingelheim International GmbH
- Endo International PLC
- Mallinckrodt PLC
- Sanofi S.A.
- Pfizer, Inc.
- Teva Pharmaceuticals Industries Ltd.
- Sun Pharmaceutical Industries Ltd.
- Purdue Pharma L.P.
Unique Offerings from the publisher
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Europe Opioids Market by Application
Chapter 4. Europe Opioids Market by Product Type
Chapter 5. Europe Opioids Market by Country
Chapter 6. Company Profiles
Companies Mentioned
- Johnson & Johnson
- AstraZeneca PLC
- Boehringer Ingelheim International GmbH
- Endo International PLC
- Mallinckrodt PLC
- Sanofi S.A.
- Pfizer, Inc.
- Teva Pharmaceuticals Industries Ltd.
- Sun Pharmaceutical Industries Ltd.
- Purdue Pharma L.P.
Methodology
LOADING...
